FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Fluvastatin Capsules Recall

Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharma…

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class II
Reported by FDA
Jul 16, 2014
Recall ID
D-1430-2014
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Fluvastatin Capsules starting May 29, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1430-2014 on Jul 16, 2014. Reason: Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.

Product description

Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals, Sellersville, PA, by Teva Pharmaceutical IND LTD, Jerusalem, Israel, NDC 0093-7442-56

Lot numbers, UPCs & expiration codes

Lot #: F47008, Exp. 7/2015

Where it was sold

Nationwide and Guam, Puerto Rico, American Samoa, Virgin Islands

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1430-2014
Classification
Class II
Status
Terminated
Recall initiated
May 29, 2014
FDA report date
Jul 16, 2014
Quantity
8,472 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-1430-2014, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
68441
Address
1090 Horsham Rd
Code information
Lot #: F47008, Exp. 7/2015
Postal code
19454-1505
Report date
Jul 16, 2014
Product type
Drugs
Recall number
D-1430-2014
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
8,472 Bottles
Termination date
Mar 9, 2015
Reason for recall
Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals, Sellersville, PA, by Teva Pharmaceutical IND LTD, Jerusalem, Israel, NDC 0093-7442-56
Distribution pattern
Nationwide and Guam, Puerto Rico, American Samoa, Virgin Islands
Recall initiation date
May 29, 2014
Initial firm notification
Letter
Center classification date
Jul 10, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1430-2014, published Jul 16, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls